In our study, the promoter methylation levels of cGAS and MAVS were elevated, which may affect the function of innate immunity of the cGAS/STING and RIG-I/MAVS pathways in the development of CPL. The gene discussed is RIGI; the disease is congenital pulmonary lymphangiectasia.